GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...

An application was submitted to the European Medicines Agency seeking approval for treatment with sugemalimab in stage 3 ...

The European Medicines Agency accepts GSK's regulatory filing for expanded use of Nucala to treat COPD for review.

The drug shortages are the result of manufacturing problems, increased demand, and other issues. View on euronews ...

The European Medicines Agency (EMA) gave its approval to an artificial intelligence diagnostic tool for the first time on ...

This approval was followed by Takeda Pharmaceuticals’ Alofisel (darvadstrocel), which received approval from the European Medicines Agency in 2018 and from Japan’s Pharmaceuticals and Medical Devices ...

Pfizer's Covid-19 vaccine is considered by healthcare authorities to be safe and effective, with data gathered from billions ...

The psoriasis market is estimated at $30 Billion by 2030 and has shifted significantly to oral drugs Ramat Gan, Israel, March ...

To avoid overlaps, the industry is calling for aligning MDR/IVDR with the EU's digital frameworks, pharmaceutical regulations ...

Patients and budgets usually come first when deciding which drug is prescribed. But what if the most environmentally sustainable product also benefited the patient?

CStone Pharmaceuticals ('CStone', HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, today announced the submission of a Type II variation application to the ...